A recent legal agreement could begin to reverse months of disruption for colleges and universities whose researchers saw critical federal grants frozen or canceled under Trump-era directives at the National Institutes of Health (NIH).
Under the agreement, the National Institutes of Health has committed to individually reviewing hundreds of scientific grant applications that were stalled, denied, or administratively withdrawn last year after agency officials implemented ideologically driven policy directives. The lawsuit was brought by the American Civil Liberties Union, along with partner organizations, on behalf of researchers and professional associations whose work was abruptly halted.
For higher education institutions, the agreement represents a potential reopening of a funding pipeline that supports not only biomedical discovery, but also faculty careers, graduate training, and institutional research capacity. NIH grants are among the most competitive and consequential funding sources in academia, underwriting labs, postdoctoral positions, and long-term research agendas across public and private universities.
According to the ACLU, the affected applications span urgent public health topics including HIV prevention, Alzheimer’s disease, LGBTQ+ health, and sexual violence—areas where universities often serve as the primary engines of research and innovation. Many of the grants had already undergone peer review or were well into the application process before being frozen.
“This agreement allows my grant application, and many others, to move forward for review after an arbitrary and destructive freeze,” said Nikki Maphis, a postdoctoral researcher at the University of New Mexico and one of the plaintiffs. “I’m building a career around studying the aging brain, with a particular focus on Alzheimer’s disease and alcohol use. I look forward to having my funding proposal evaluated fairly so that I can continue contributing to urgent and unmet public health needs.”
The agreement requires NIH to evaluate the affected applications using its standard scientific review process and explicitly bars the agency from applying the challenged directives. It also establishes firm deadlines for decisions, some as soon as January 2026, and clarifies that the close of federal fiscal year 2025 does not prevent NIH from making awards, subject to congressional appropriations.
For colleges and universities, the fallout from the earlier grant cancellations extended well beyond individual projects. Training grants aimed at expanding participation in biomedical research—particularly for scholars from historically underrepresented backgrounds—were also swept up in the purge. Higher education groups warned that the disruptions jeopardized years of work, destabilized labs, and placed early-career researchers in precarious positions.
“Researchers deserve to have their work evaluated on its merits, not sidelined by political interference,” said Olga Akselrod, senior counsel in the ACLU Racial Justice Program. “NIH has now agreed to review the stalled applications individually and in good faith, without applying the unlawful policy directives.”
The agreement does not fully resolve the broader legal fight. Earlier this year, a federal district court ruled that NIH’s directives violated the Administrative Procedure Act, though the U.S. Supreme Court later limited the court’s jurisdiction over grant terminations. That decision is now on appeal, with oral arguments scheduled before the First Circuit Court of Appeals in January 2026.
Still, higher education leaders and researchers see the agreement as a partial but meaningful step toward restoring confidence in federal research funding. As Kenneth Parreno of Protect Democracy put it, “By committing to evaluate these NIH grant applications on their scientific merit, not on political ideology, the federal government is taking a necessary step to ensure that facts, evidence, and the rule of law guide the decisions that shape our nation’s health and innovation.”
Whether the reviews ultimately result in restored funding remains uncertain. But for campuses that depend on stable, merit-based federal research support, the agreement signals a potential shift away from political interference—and a chance to resume work that many institutions say should never have been paused in the first place.
